Wells Fargo & Company MN Has $11.99 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

Wells Fargo & Company MN raised its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 4.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 124,940 shares of the company's stock after purchasing an additional 5,594 shares during the quarter. Wells Fargo & Company MN owned approximately 0.14% of HealthEquity worth $11,988,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQY. Barclays PLC grew its position in shares of HealthEquity by 209.3% in the third quarter. Barclays PLC now owns 166,492 shares of the company's stock valued at $13,628,000 after purchasing an additional 112,667 shares during the last quarter. Sanctuary Advisors LLC bought a new stake in HealthEquity in the 3rd quarter valued at $260,000. Wilmington Savings Fund Society FSB acquired a new position in HealthEquity in the 3rd quarter valued at $150,000. Franklin Resources Inc. increased its position in HealthEquity by 0.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock worth $139,369,000 after buying an additional 11,659 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in shares of HealthEquity by 32.9% during the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company's stock worth $120,000 after buying an additional 309 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

HQY has been the topic of a number of recent research reports. Wells Fargo & Company raised their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. The Goldman Sachs Group lowered their target price on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. KeyCorp cut their price target on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, Barrington Research reissued an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, HealthEquity currently has an average rating of "Buy" and an average target price of $111.75.

HealthEquity Price Performance

Shares of HQY traded up $2.03 during trading hours on Friday, reaching $84.52. The stock had a trading volume of 944,006 shares, compared to its average volume of 764,227. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The stock has a market capitalization of $7.31 billion, a PE ratio of 77.54, a PEG ratio of 1.60 and a beta of 0.49. The company's 50-day moving average is $95.34 and its two-hundred day moving average is $96.28.

Insider Buying and Selling at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 20,381 shares of company stock worth $1,781,432. 2.20% of the stock is currently owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.